Interventional Oncology Market: Competitive Landscape & Technological Breakthroughs Analysis

1
MarketsandMarkets Presents
Interventional Oncology Market worth 2.9 billion
by 2026
https//www.marketsandmarkets.com/Market-Reports/i
nterventional-oncology-market-203687164.html
2
The report "Interventional Oncology Market by
Product (Radiofrequency, microwave, embolization,
guidewires), Procedure (Thermal, Non-Thermal
Ablation, TACE, TARE, TAE), Cancer (Liver, Lung,
Kidney, Bone Metastasis), Enduser (Hospital, ASC)
- Global Forecast to 2026" The global
interventional oncology market size is estimated
to be USD 1.9 billion in 2020 and is projected to
reach USD 2.9 billion by 2026, at a CAGR of 6.8.
The increasing prevalence of diseases and
disorders, technological advancements, and
increased funding and public-private investments
are the key factors driving the growth of the
interventional oncology market. Download a PDF
Brochure https//www.marketsandmarkets.com/pdfdow
nload
3

• Objectives of the Study
• Demand for embolization devices result in the
  segment occupying the high share of the
  interventional oncology market
• Liver cancer estimated to be the growing market
• Liver cancer accounted for the largest share of
  the interventional oncology market in 2020.
  Interventional oncology plays a crucial role in
  treating liver cancer, as removing the tumor with
  surgery may not leave the tissue healthy enough
  for effective liver functioning. Thus, primary
  liver tumors or liver tumors resulting from
  metastatic cancers can effectively be treated
  using interventional oncology procedures. Owing
  to this, more than half of all treatments for
  primary and metastatic liver cancer are conducted
  using interventional oncology.
• Asia Pacific likely to emerge as the
  fastest-growing interventional oncology market,
  globally
• Speak to Analyst https//www.marketsandmarkets.co
  m/speaktoanalyst

4
This research report categorizes the
interventional oncology market based on product,
procedure, cancer type, end user, and region.

• By Product
• Embolization Devices
• Ablation Devices
• Support Devices
• By Procedure
• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization/Selective
  Internal Radiation Therapy
• Transcatheter Arterial Embolization/Bland
  Embolization
• By Cancer Type
• Liver Cancer
• Lung Cancer
• Bone Metastasis
• Kidney Cancer
• Breast Cancer
• Prostate Cancer

5

Medtronic, Boston Scientific, BD, Terumo, Merit
Medical, AngioDynamics, JJ, Teleflex, Cook
Medical, HealthTronics, MedWaves, Sanarus,
IMBiotechnologies, Trod Medical, IceCure Medical,
Mermaid Medicals, Interface Biomaterials BV,
Guerbet, ABK Biomedical, Shape Memory Medical,
Endo Shape, Monteris Medical, Instylla, Trisalus
Lifesciences, Profound Medical Corp, Sirtex,
Accuray, Baylis Medical, and ALPINION MEDICAL
SYSTEMS and Among Others
6
Companies Insight
Boston Scientific (US) dominated the global
interventional oncology market in 2020. The
company mainly focuses on growth strategies such
as acquisitions and expansions to increase its
market presence and product offerings. The
companys plan to acquire BTG will help expand
its product offerings in chemoembolization,
radioembolization, and ablation therapies. Boston
Scientific constantly strives to gain regulatory
and reimbursement approvals. As a part of its
long-term growth strategy, the company invests in
fast-growing markets as well as new markets by
strengthening its position in the global
healthcare market. Medtronic (Ireland) held the
second position in the global interventional
oncology market in 2020. The company focuses on
adopting various organic growth strategies like
product launches approvals and inorganic growth
strategies, such as acquisitions and
collaborations, to expand its presence and share
in the interventional oncology market. In line
with this, the company launched various tumor
management products like OptiSphere Embolization
Spheres and OsteoCool Rf Ablation Systems and
received US FDA clearance, which helped it to
expand its presence in the market.
7
Contact Us
ContactMr. Aashish MehraMarketsandMarkets
INC. 630 Dundee Road, Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 sales_at_marketsandmarkets
.com Press release https//www.marketsandmarkets
.com/PressReleases/interventional-oncology.asp Re
search insights https//www.marketsandmarkets.com
/ResearchInsight/interventional-oncology-market.as
p
8
About MarketsandMarkets
MarketsandMarkets provides quantified B2B
research on 30,000 high growth niche
opportunities/threats which will impact 70 to
80 of worldwide companies revenues. Currently
servicing 5000 customers worldwide including 80
of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets
for their painpoints around revenues
decisions. Our 850 fulltime analyst and SMEs at
MarketsandMarkets are tracking global high
growth markets following the "Growth Engagement
Model GEM". The GEM aims at proactive
collaboration with the clients to identify new
opportunities, identify most important customers,
write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both
the company and its competitors.
MarketsandMarkets now coming up with 1,500
MicroQuadrants (Positioning top players across
leaders, emerging companies, innovators,
strategic players) annually in high growth
emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.